EMEA-000498-PIP01-08-M08

Key facts

Invented name
Trajenta
Active substance
linagliptin
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0204/2018
PIP number
EMEA-000498-PIP01-08-M08
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of type 2 diabetes mellitus
Route(s) of administration
Oral use
Contact for public enquiries
Boehringer Ingelheim International GmbH
Tel. +49 6132770
E-mail: paediatrics@boehringer-ingelheim.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating